Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY2623091 in Participants With High Blood Pressure

ClinicalTrials.gov ID: NCT02194465

Public ClinicalTrials.gov record NCT02194465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blinded, Parallel, Phase 2a Study to Evaluate the Safety and Efficacy of LY2623091 in Patients With Primary Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY2623091 in participants with high blood pressure.

Study identification

NCT ID
NCT02194465
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
304 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Feb 28, 2015
Completion
Feb 28, 2015
Last update posted
Jun 25, 2020

2014 – 2015

United States locations

U.S. sites
33
U.S. states
19
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Advantage Glendale Arizona 85306
John Muir Health Network - The Osteoporosis Center Concord California 94520
Encompass Clinical Research Encinitas California 92024
Avail Clinical Research LLC DeLand Florida 32720
Alan Graff, MD, PA Fort Lauderdale Florida 33308
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Cardiovascular Center of Sarasota Sarasota Florida 34239
East West Medical Institute Honolulu Hawaii 96814
Rocky Mountain Diabetes and Osteoporosis Center Idaho Falls Idaho 83404
Northwest Heart Clinical Research, LLC Arlington Heights Illinois 60005
Cedar-Crosse Research Center Chicago Illinois 60607
Midwest Institute for Clinical Research Indianapolis Indiana 46260
Community Clinical Research Center Muncie Indiana 47304
Heartland Research Associates Wichita Kansas 67207
Grace Research Bossier City Louisiana 71111
Maine Research Associates Auburn Maine 04210
AB Clinical Trials Las Vegas Nevada 89119
Rochester Clinical Research, Inc. Rochester New York 14609
Metrolina Internal Medicine, P.A. Charlotte North Carolina 28204
PharmQuest Greensboro North Carolina 27408
Lillestol Research LLC Fargo North Dakota 58103
Sterling Research Group, LTD Cincinnati Ohio 45219
Rapid Medical Research Inc Cleveland Ohio 44122
Columbus Clinical Research Columbus Ohio 43213
Dayton Clinical Research Dayton Ohio 45406
Cor Clinical Research LLC Oklahoma City Oklahoma 4052728481
Oklahoma Foundation For Cardiovascular Research Oklahoma City Oklahoma 73120
Mountain View Clinical Research, Inc Greer South Carolina 29651
Texas Diabetes and Endocrinology Austin Texas 78731-4309
Tekton Research, Inc Austin Texas 78745
Texas Diabetes and Endocrinology, P.A. Round Rock Texas 78681
Northwest Clinical Research Center Bellevue Washington 98007-4209
Universal Research Group, LLC Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02194465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02194465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →